News

Meggle Group Wasserburg has been granted an EXCiPACT certificate.

Conventional tablets may no longer be the go-to solution.

Industry associations play a strong role in helping the pharmaceutical industry meet challenges.

The National Institute of Allergy and Infectious Diseases will begin the first in a series of trials for an Ebola vaccine during the week of Sept. 1.

ISPE released an advance look at the Introductory Summary of its Drug Shortages Prevention Plan.

FDA found violations of cGMP at finished-drug manufacturer in India.

Concerns about quality in overseas production may bring generic drug production back to the United States, concludes CPhI study.

Consumers warned about products claiming to prevent or treat the Ebola virus.

Cubist Pharmaceuticals voluntarily recalls certain lots of CUBICIN 500 mg in 10 mL single-use vials because of the presence of particulate matter.

The European system for assessing drugs will be used as a model internationally.

PharmaChk, a portable device being developed to detect substandard medicines, receives $2-million grant.

Allied-Bristol Life Sciences will focus on converting university research into therapeutic candidates.

GlobalData's report looks at the growth of monoclonal antibodies in the market for acute coronary syndrome treatment.

ChargePoint Technology announced that it has acquired the assets of Forac Limited.

BioSpectra's Pennsylvania facility will manufacture biological buffers, pharmaceutical excipients, and laboratory reagents.

Metrics Contract Services adopts a more descriptive name and brand that identifies it as being part of the Mayne Pharma global family.

Acquisition of Almirall?s products will provide boost to revenue and strengthen AstraZeneca?s respiratory product line.

EMA has released the second module of a new guideline on influenza vaccines for a six-month public consultation. The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication of a module on the quality requirements.

Catalent?s $870 million IPO will help company reduce debt, enable future growth.

The latest revisions to the USP General Chapters <41> Balances and <1251> Weighing on an Analytical Balance aim to ensure weighing accuracy and eliminate unnecessary overtesting by simplifying previous descriptions and reflecting current state-of-the-art weighing practices.

Hovione announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by FDA.

A review of how mergers and acquisitions have shaped the pharmaceutical industry landscape.

Pharmaceutical Technology Europe Marks 25 years of drug-development advances.

Pfizer announced an agreement to acquire Baxter International?s marketed vaccines for $635 million.

FDA issues a warning letter to Zhejiang Jiuzhou Pharmaceutical Co., Ltd. and its import/export company for multiple CGMP violations and misbranded products.

Croda, an excipients supplier, announced that it has obtained EXCiPACT certification for its excipients manufacturing site at Mevisa, Spain.

Redbiotec and GE Healthcare Life Sciences develop a novel manufacturing process for virus-like particles.

SGS to add testing laboratories for biotechnology, extractables and leachables, and elemental impurities to Shanghai facility.

The regulatory filing marks the first step in the approval process toward making RTS,S available as an addition to existing tools currently recommended for malaria prevention.

Packaging Coordinators, Inc. expands its services with acquisition of Penn Pharmaceutical Services.